• Silo Pharma will hold its 2026 annual shareholder meeting in Sarasota, Florida on Aug. 14, 2026.
• Shareholders will vote to elect four directors to one-year terms.
• Ballots also cover auditor ratification for the year ending Dec. 31, 2026.
• Investors will vote on a charter amendment to raise authorized common shares to 250,000,000 from 6,666,667.
• A separate proposal seeks authorization to adjourn the meeting to solicit additional proxies if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-070208), on June 18, 2026, and is solely responsible for the information contained therein.